Skip to main content
SA Policy Space

Technology Innovation Agency 2.0 Reform

Innovation & R&DUnder reviewMedium TermRaised 2× in committeeScience, Technology and Innovation

Theme: Innovation commercialisation

First raisedOct 2025Last discussedFeb 20262 meetings on the record ↓

Reform at a glance

What changes
Technology Innovation Agency 2.0 Reform
Responsible actor (recorded)
DSI / TIA / dtic
Recorded status
Under review — editorial assessment.
Milestone described by this status
Status scope has not yet been independently documented; it may cover only part of this reform.
Next documented milestone
Next milestone not yet documented
Compare shortlist (0/3)
Back to ideas
On this page

Description

The Technology Innovation Agency (TIA), established under the DSI in 2008, provides bridge funding between academic research and commercial scale-up with an annual budget of approximately R900 million. TIA has supported over 200 companies, but its commercialisation success rate—measured by IP licences, spinouts reaching revenue, and jobs created—is below international benchmarks. Reform involves restructuring TIA's mandate to focus on fewer, larger bets aligned with DSI's priority sectors (green hydrogen, mining automation, health biotech), introducing co-investment requirements from industry and VC co-investors, and improving portfolio monitoring. Parliamentary Committee on Science and Innovation BRRRs noted TIA's administrative overhead absorbs 25–30% of budget and that portfolio attrition rates are high relative to comparators like Israel's BIRD Foundation.

Assessment

Growth Impact3/5
Feasibility3/5

Responsible: DSI / TIA / dtic

Feasibility Assessment

High. Administrative reform within DSI's mandate. Budget reorientation does not require legislation; TIA Act amendment only needed if mandate changes substantially.

OECD

Referenced in OECD Economic Surveys: South Africa

OECD SA Survey (2017, 2020, 2022, 2025). Related reform area identified across OECD surveys.

International Comparisons

View all →
Finland2012

Finland rebuilt its economy after the Nokia-led ICT crash (2012) by diversifying into gaming (Supercell, Rovio), cleantech, and health technology through the Tekes/Business Finland innovation funding agency and university-industry partnerships. R&D spending reached 3.3% of GDP. Business Finland funds 2,500 companies annually with non-dilutive grants of EUR 20,000–2 million linked to commercialisation milestones. Finland ranks #1 globally in university spin-off creation per student. SA's overreliance on extractives presents an analogous diversification imperative; Finland's public-risk private-upside funding model is directly transferable.

Approach

Finland's agency funds through milestone-linked, non-dilutive instruments — grants and soft loans requiring the firm to co-fund a share — so the state takes no equity and the company keeps its cap table clean for later venture rounds. Money is released against verified commercialisation milestones rather than in advance. When the dominant ICT employer contracted, the agency pushed funding directly at the released engineers and at spin-out formation, and the innovation-promotion and export-promotion agencies were later merged so a funded company met one organisation from grant to first export order. Independent impact evaluation of the portfolio is commissioned as standing practice.

Timeline: Redirection towards diversification from around 2012; gaming and cleantech sector emergence within five years; agency consolidation completed 2018

Lessons for South Africa

Finland answers the question TIA's reform brief poses as a choice between fewer larger bets and portfolio breadth: the discipline is milestone-based release, not bet size. Money arriving in tranches against verified commercialisation milestones stops the attrition the Science and Innovation committee has flagged, because a stalled project stops consuming budget. The merger of innovation and export promotion is the second lesson and the more awkward one for SA, where TIA, the IDC, SEDA and the DTIC's export incentives each hold part of a company's path to market. Finland also commissions independent portfolio evaluation as routine, which is the cheapest way to defend TIA's appropriation.

Israel1993

Israel grew from near-zero venture capital to USD 25 billion in VC investment (2021) — the world's highest VC per capita — through the Yozma programme (1993): USD 100 million in government funds co-invested with private VCs, which could buy out the government stake at cost plus interest. This structure gave VCs upside while the government bore downside risk. 97 multinational R&D centres (Intel, Microsoft, Google) now operate in Israel. Start-up exits generated USD 44 billion in 2021. SA has the human capital base; Yozma's co-investment matching structure is replicable through SEDA and the IDC.

Approach

Yozma did not fund companies; it funded fund managers. Ten venture funds were created, each pairing government capital with a foreign venture firm required to bring investment expertise and deal flow alongside its money, plus an Israeli partner. The government took a minority stake and granted the private partners a call option to buy it out at cost plus interest within five years — so the state kept the downside and gave away the upside, which is what made experienced foreign managers show up. The separate chief-scientist grant scheme repaid the state through royalties only on commercial success.

Timeline: Programme launched 1993 with the buy-out options exercised within about five years; a self-sustaining venture industry by the early 2000s

Lessons for South Africa

TIA's 25–30% administrative overhead is the cost of picking companies directly; Yozma's structure removes it by delegating selection to managers with their own capital at risk. That is the sharpest available answer to the co-investment requirement already in TIA's reform brief: rather than requiring a co-investor deal by deal, capitalise a small number of funds on Yozma terms and let them assemble portfolios in the DSI priority sectors. The asymmetric buy-out — state bears downside, private partners take the upside at cost plus interest — is what converts public money into a commercialisation pipeline, and it prices the state's contribution honestly instead of hiding it in portfolio attrition.

Evidence & Research

No linked research evidence yet. Coverage is incomplete.

Policy documents

No linked official-document evidence yet. Coverage is incomplete.

Get the Monday briefing by email

— A short weekly digest of what moved in SA policy.

Status History

tracked since Mar 2026
  1. Recorded as Under review when status tracking began — held since at least Mar 2026.
    Mar 2026

Data as of 2026-10-10 · latest PMG meeting 2026-10-02